Das S K, Chatterjee D, Uddin M
Department of Biochemistry, Meharry Medical College, 1005 D.B. Todd Boulevard, Nashville, TN 37208, USA.
Biochem Biophys Res Commun. 2002 Apr 26;293(1):412-5. doi: 10.1016/S0006-291X(02)00250-4.
Kallikreins are a group of specific serine proteases and are an integral part of kallikrein-kinin system. The kallikrein-kinin system is hypotensive in nature and counteracts with the renin-angiotensin system in the maintenance of normal blood pressure. So far, four kallikrein-like enzymes, namely, mK9, mK13, mK22, and mK26, have been known to convert the inactive pro-renin into biologically active renin. Some of these enzymes are induced by the thyroid hormone. In the proposed study, we investigated the effects of thyroid hormone on the expression of genes for mk9, mk13, and mk22 enzymes. We used guinea pigs as models because these animals share many characteristics in common to humans. Male adult guinea pigs were intramuscularly injected with 2 mg/kg body weight of thyronine. Forty-eight hours following the last injection, the liver was processed for Northern blot analysis using labeled mK9, mK13, and mK22 specific RNA probes. Only mK9 was found to be transcriptionally regulated by the hormone.
激肽释放酶是一组特定的丝氨酸蛋白酶,是激肽释放酶-激肽系统的一个组成部分。激肽释放酶-激肽系统本质上具有降血压作用,在维持正常血压方面与肾素-血管紧张素系统相互拮抗。到目前为止,已知四种激肽释放酶样酶,即mK9、mK13、mK22和mK26,可将无活性的肾素原转化为具有生物活性的肾素。其中一些酶由甲状腺激素诱导产生。在本研究中,我们调查了甲状腺激素对mk9、mk13和mk22酶基因表达的影响。我们使用豚鼠作为模型,因为这些动物与人类有许多共同特征。成年雄性豚鼠肌肉注射2mg/kg体重的甲状腺素。最后一次注射后48小时,取肝脏进行Northern印迹分析,使用标记的mK9、mK13和mK22特异性RNA探针。结果发现只有mK9受该激素的转录调控。